XML 55 R33.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Share - Based Compensation (Tables)
 12 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of share based compensation expense
Following approval by the Company's shareholders in October 2023, the 2023 Long-Term Performance Plan (the "2023 Plan") replaced the 2019 Long-Term Performance Plan. The 2023 Plan, which expires in 2028, provides for granting of SARs, stock options, stock awards, cash awards, and such other awards or combination thereof as the Executive Organization and Compensation Committee or, in the case of director awards, the Corporate Governance & Sustainability Committee of the Board of Directors (together referred to as the "Committee") may determine to officers, other key employees and members of the Board of Directors. Grants are generally made at regularly scheduled committee meetings. Compensation costs charged to expense under award programs paid (or to be paid) with shares (including SARs, performance shares, restricted stock, and RSUs) are summarized in the table below:
Year Ended June 30,202420232022
SARs$3,448 $2,785 $3,284 
Performance shares4,232 5,302 4,549 
Restricted stock and RSUs5,264 4,274 4,009 
Total compensation costs under award programs$12,944 $12,361 $11,842 
Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]
The aggregate unrecognized compensation cost for share-based award programs with the potential to be paid at June 30, 2024 is summarized in the table below:
June 30,2024Average Expected Period of Expected Recognition (Years)
SARs$5,113 2.6
Performance shares6,415 1.7
Restricted stock and RSUs3,050 2.1
Total unrecognized compensation costs under award programs$14,578 2.1
Weighted-average assumptions used for SARs and stock option grants issued
The weighted-average assumptions used for SARs grants issued in fiscal 2024, 2023, and 2022 are:
202420232022
Expected life, in years6.06.26.4
Risk free interest rate4.1 %2.9 %1.0 %
Dividend yield1.0 %1.3 %1.5 %
Volatility37.0 %35.5 %34.3 %
Per share fair value of SARs granted during the year$55.65$35.98$26.18
Summary of SARs and stock option activity
A summary of SARs and stock options activity is presented below:
SharesWeighted-Average
Exercise Price
Year Ended June 30, 2024
(Shares in thousands)
Outstanding, beginning of year816 $70.11 
Granted102 143.72 
Exercised(188)61.25 
Forfeited(18)83.67 
Outstanding, end of year712 $82.65 
Exercisable at end of year472 $65.93 
Expected to vest at end of year706 $82.29 
Schedule of Nonvested Performance-Based Units Activity
A summary of non-vested performance shares activity at June 30, 2024 is presented below:
Shares
Weighted-Average
Grant-Date
Fair Value
Year Ended June 30, 2024
(Shares in thousands)
Non-vested, beginning of year159 $66.74 
Awarded42 99.79 
Vested(100)53.50 
Non-vested, end of year101 $93.73 
Schedule of Nonvested Restricted Stock Units Activity
A summary of the status of the Company’s non-vested restricted stock and RSUs at June 30, 2024 is presented below:
Shares
Weighted-Average
Grant-Date
Fair Value
Year Ended June 30, 2024
(Share amounts in thousands)
Non-vested, beginning of year143 $83.35 
Granted29 151.53 
Forfeitures(4)84.96 
Vested(38)81.50 
Non-vested, end of year130 $99.05